Erratum: Lycopene and beta-carotene induce growth inhibition and proapoptotic effects on ACTH-secreting pituitary adenoma cells (PLoS ONE (2013) 8:5 (e62773) DOI: 10.1371/journal.pone.0062773);Lycopene and Beta-Carotene Induce Growth Inhibition and Proapoptotic Effects on ACTH-Secreting Pituitary Adenoma Cells

PLoS ONE

Volumn 8, Issue 5, 2013, Pages

  Haddad, Natália F ^a   Teodoro, Anderson J ^a,b   Leite de Oliveira, Felipe ^a   Soares, Nathália ^a   de Mattos, Rômulo Medina ^a   Hecht, Fábio ^a   Dezonne, Rômulo Sperduto ^a   Vairo, Leandro ^a   Goldenberg, Regina Coeli dos Santos ^a   Gomes, Flávia Carvalho Alcântara ^a   de Carvalho, Denise Pires ^a   Gadelha, Mônica R ^a   Nasciutti, Luiz Eurico ^a   Miranda Alves, Leandro ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; CONNEXIN 43; CORTICOTROPIN; CYCLIN DEPENDENT KINASE INHIBITOR 1B; LYCOPENE; S PHASE KINASE ASSOCIATED PROTEIN 2;

ACTH SECRETING ADENOMA; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CELL COMMUNICATION; CELL VIABILITY; CLONOGENESIS; COLONY FORMATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOTROPIN RELEASE; CUSHING SYNDROME; DRUG EFFECT; DRUG MECHANISM; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GAP JUNCTION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; S PHASE CELL CYCLE CHECKPOINT;

EID: 84877119338     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0149157     Document Type: Erratum

References (67)

1. Daly AF, Burlacu MC, Livadariu E, Beckers A, (2007) The epidemiology and management of pituitary incidentalomas. Horm Res 68: 195-198.
2. Labeur M, Paez-Perada M, Arzt E, Stalla GK, (2008) Potential of retinoic acid derivatives for the treatment of corticotroph pituitary adenomas. Rev Endocr Metab Disord 10: 103-109.
3. Schaaf C, Shan B, Buchfelder M, Losa M, Kreutzer J, et al. (2009) Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumor cells in vitro and in vivo. Endocr Relat Cancer 16: 1339-1350.
4. Bangaru MLY, Woodliff J, Raff H, Kansra S, (2010) Growth suppression of mouse pituitary corticotroph tumor AtT-20 cells by curcumin: a model for treating Cushing's Disease. PloS One 5: e9893.
5. Neggers SJ, Van der Lely AJ, (2011) Pegvisomant and improvement of quality of life in acromegalic patients. Horm Res Paediatr 76 Suppl 1: 102-105.
6. Sathyapalan T, Dixit S, (2012) Radiotherapy-induced hypopituitarism: a review. Expert Rev Anticancer Ther 12: 669-683.
7. Pivonello R, Ferone D, de Herder WW, de Krijger RR, Waaijers M, et al. (2004) Dopamine receptor expression and function in human normal adrenal gland and adrenal tumors. J Clin Endocrinol Metab 89: 4493-4502.
8. Thedoropoulou M, Labeur M, Paez-Pereda M, Haedo M, Perone MJ, et al. (2010) Novel medical therapies for pituitary tumors. Front Horm Res 38: 158-164.
9. Sakagami Y, Berthoud VM, Sumiya Y, Komemushl S, (2010) Research on search of the carotenoid-producing microorganisms in marine area and the improvement of production ratio. Yakugaku Sasshi/The Pharm Society 130: 1445-1451.
10. Kelkel M, Schumacher M, Dicato M, Diederich M, (2011) Antioxidant and anti-proliferative properties of lycopene. Free Radical Res 45: 925-940.
11. Yang CM, Yen YT, Huang CS, Hu ML, (2011) Growth inhibitory efficacy of lycopene and β-carotene against androgen-independent prostate tumor cells xenografted in nude mice. Mol Nutr Food Res 55: 606-612.
12. Palozza P, Bellovino D, Simone R, Boninsegna A, Cellini F, et al. (2009) Effect of beta-carotene-rich tomato lycopene beta-cyclase (tlcy-b) on cell growth inhibition in HT-29 colon adenocarcinoma cells. Br J Nutr 102: 207-214.
13. Tang FY, Shih CJ, Cheng LH, Ho HJ, Chen HJ, (2008) Lycopene inhibits growth of human colon cancer cells via suppression of the AKt signaling pathway. Mol Nutr Food Res 52: 646-654.
14. Hix LM, Lockwood SF, Bertram JS, (2004) Upregulation of connexin 43 protein expression and increased gap junctional communication by water soluble disodium disuccinate astaxanthin derivatives. Cancer Lett 211: 25-37.
15. Chalbi N, Delort L, Satih S, Déchelotte P, Bignon YJ, et al. (2007) Immunohistochemical expression of RARalpha, RARbeta, and Cx43 in breast tumor cell lines after treatment with lycopene and correlation with RT-qPCR. J Histochem Cytochem 55: 877-883.
16. Long AC, Bomser JA, Grzybowski DM, Chandler HL, (2010) All-trans retinoic acid regulates cx43 expression, gap junction communication and differentiation in primary lens epithelial cells. Curr Eye Res 35: 670-679.
17. Vinken M, Decrock E, Leybaert L, Bultynck G, Himpens B, et al. (2012) Non-channel functions of connexins in cell growth and cell death. Biochim Biophys Acta 1818: 2002-2008.
18. Furth J, Gadsen EL, Upton AC, (1956) ACTH secreting transplantable pituitary tumors. Proc Soc Exp Biol Med 84: 253-254.
19. Buonassisi V, Sato G, Cohen AI, (1962) Hormone-producing cultures of adrenal and pituitary tumor origin. Proc Natl Acad Sci USA 48: 1184-1190.
20. Vindelov LL, (1977) Flow microfluorometric analysis of nuclear DNA in cells from solid tumors and cell suspensions. A new method for rapid isolation and straining of nuclei. Virchows Arch B Cell Pathol 24: 227-242.
21. Klein SB, Fisher GJ, Jensen TC, Mendelsohn J, Voorhees JJ, et al. (1992) Regulation of TGF-alpha expression in human keratinocytes: PKC-dependent and -independent pathways. J Cell Physiol 15: 326-336.
22. Labeur M, Theodoropoulou M, Sievers C, Paez-Pereda M, Castillo V, et al. (2006) New aspects in the diagnosis and treatment of Cushing disease. Front Horm Res. 35: 169-178.
23. Targher G, (2012) Pasireotide in Cushing's disease. N Engl J Med 366: 2134-2135.
24. Libé R, Groussin L, Bertherat J, (2012) Pasireotide in Cushing's Disease. N Engl J Med 366: 2134-2135.
25. Kotake-Nara E, Kushiro M, Zhang H, Sugawara T, Miyashita K, et al. (2001) Carotenoids affect proliferation of human prostate cancer cells. J Nutr 131: 3303-3306.
26. Al-Wadei HA, Schuller HM, (2009) Non-genomic inhibitory signaling of beta-carotene in squamous cell carcinoma of the lungs. Int J Oncol 34: 1093-1098.
27. Jang SH, Lim JW, Kim H, (2009) Mechanism of beta-carotene-induce apoptosis of gastric cancer cells: involvement of ataxia-telangiectasia-mutated. Ann N Y Acad Sci 1171: 156-162.
28. Talvas J, Caris-Veyrat C, Guy L, Rambeau M, Lyan B, et al. (2010) Differential effects of lycopene consumed in tomato paste and lycopene in the form of a purified extract on target genes of cancer prostatic cells. Am J Clin Nutr 91: 1716-1724.
29. Pan SY, Zhou J, Gibbons L, Morrison H, Wen SW, (2011) Antioxidants and breast cancer risk- a population-based case-control study in Canada. BMC Cancer 11: 372.
30. Teodoro AJ, Oliveira FL, Martins NB, Maia GA, Martucci RB, et al. (2012) Effect of lycopene on cell viability and cell cycle progression in human cancer cell lines. Cancer Cell Int 12: 36-44.
31. Vogt TM, Mayne ST, Graubard BI, Swanson CA, Sowell AL, et al. (2002) Serum lycopene, other serum carotenoids, and risk of prostate cancer in US Blacks and Whites. Am J Epidemiol. 155: 1023-32.
32. Yang Z, Zhang Z, Penniston KL, Binkley N, Tanumihardjo SA, (2008) Serum carotenoid concentrations in postmenopausal women from the United States with and without osteoporosis. Int J Vitam Nutr Res. 78: 105-11.
33. Miller M, Chen S, Woodliff J, Kansra S, (2008) Curcumin (diferuloylmethane) inhibits cell proliferation, induces apoptosis, and decreases hormone levels and secretion in pituitary tumor cells. Endocrinology 149: 4158-4167.
34. Schaaf C, Shan B, Onofri C, Stalla GK, Artz E, et al. (2010) Curcumin inhibits the growth, induces apoptosis and modulates the function of pituitary folliculostellate cells. Neuroendocrinology 91: 200-210.
35. Ben-Dor A, Nahum A, Danilenko M, Giat Y, Stahl W, et al. (2001) Effects of acyclo-retinoic acid and lycopene on activation of the retinoic acid receptor and proliferation of mammary cancer cells. Arch Biochem Biophys 391: 295-302.
36. Martucci RB, Ziulkoski AL, Fortuna VA, Guaragna RM, Guma FC, et al. (2004) Beta-carotene storage, conversion to retinoic acid, and induction of the lipocyte phenotype in hepatic stellate cells. J Cell Biochem. 92: 414-423.
37. Teodoro AJ, Perrone D, Martucci RB, Borojevic R, (2009) Lycopene isomerisation and storage in vitro model of murine hepatic stellate cells. Eur J Nutr 48: 261-268.
38. Nahum A, Zeller L, Danilenko M, Prall OW, Watts CK, et al. (2006) Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1. Eur J Nutr 45: 275-282.
39. Palozza P, Serini S, Boninsegna A, Bellovino D, Lucarini M, et al. (2007) The growth-inhibitory effects of tomatoes digested in vitro in colon adenocarcinoma cells occur through down regulation of cyclin D1, Bcl-2 and Bcl-xL. Br J Nutr 98: 789-795.
40. Palozza P, Colangelo M, Simone R, Catalano A, Boninsegna A, et al. (2010) Lycopene induces cell growth inhibition by altering mevalonate pathway and Ras signaling in cancer cell lines. Carcionogenesis 31: 1813-1821.
41. Hwang ES, Bowen PE, (2004) Cell cycle arrest and induction of apoptosis by lycopene in LNCaP human prostate cancer cells. J Med Food 7: 284-289.
42. Palozza P, Serini S, Maggiano N, Angelini M, Boninsegna A, et al. (2002) Induction of cell cycle arrest and apoptosis in human colon adenocarcinoma cell lines by beta-carotene through down-regulation of cyclin A and Bcl-2 family proteins. Carcinogenesis 23: 11-18.
43. Nahum A, Hirsch K, Danilenko M, Watts CK, Prall OW, et al. (2001) Lycopene inhibition of cell cycle progression in breast and endometrial cancer cells is associated with reduction in cyclin D levels and retention of p27(Kip1) in the cyclin E-cdk2 complexes. Oncogene 20: 3428-3436.
44. Bertram JS, (2004) Dietary carotenoids, connexins and cancer: what is the connection? Biochem Soc Trans 32: 985-989.
45. Bertram JS, (2004) Bioctive carotenoids: potent antioxidants and regulators of gene expression. Redox Rep 9: 181-191.
46. Fornelli F, Leone A, Verdesca I, Minervini F, Zacheo G, (2007) The influence of lycopene on the proliferation of human breast cell line (MCF-7). Toxicol In Vitro 21: 217-23.
47. Liu NA, Jiang H, Ben-Shlomo A, Wawrowsky K, Fan XM, et al. (2012) Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor. Proc Natl Acad Sci 108: 8414-8419.
48. Kiec-Wilk B, Sliwa A, Mikolajczyk M, Malecki MT, Mathers JC, (2011) The CpG island methylation regulated expression of endothelial proangiogenic genes in response to β-carotene and arachidonic acid. Nutr Cancer 63: 1053-1063.
49. Dbouk HA, Mroue RM, El-Sabban E, Talhouk RS, (2009) Connexins: a myriad of functions extending beyond assembly of gap junction channels. Cell Commun Signal 7: 4.
50. Leithe E, Kjenseth A, Bruun J, Sirnes S, Rivedal E, (2010) Inhibition of connexin 43 gap junction channels by the endocrine disruptor ioxynil. Toxicol Appl Pharmacol 247: 10-17.
51. Márquez-Rosado L, Solan JL, Dunn CA, Norris RP, Lampe PD, (2012) Connexin43 phosphorylation in brain, cardiac, endothelial and epithelial tissues. Biochim Biophys Acta 1818: 1985-1992.
52. Lampe PD, Kurata WE, Warn-Cramer BJ, Lau AF, (1998) Formation of a distinct connexin43 phosphoisoform in mitotic cells is dependent upon p34cdc2 kinase. J Cell Sci. 111: 833-841.
53. Kanemitsu MY, Jiang W, Eckhart W, (1998) Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ. 1998 Jan 9(1): 13-21.
54. Ruch RJ, Klaunig JE, Pereira MA, (1987) Inhibition of intercellular communication between mouse hepatocytes by tumor promoters. Toxicol Appl Pharmacol 87: 111-120.
55. Sies H, Stahl W, (1998) The role of carotenoids and retinoids in gap functional communication. Int J Vitam Nutr Res 68: 354-359.
56. Moennikes O, Stahl S, Bannasch P, Buchmann A, Schwarz M, (2003) WY-14,643-mediated promotion of hepatocarcinogenesis in connexin 32 wild-type and connexin32-null mice. Carcinogenesis 24: 1561-1565.
57. Ruch RJ, Klaunig JE, Pereira MA, (1987) Inhibition of intercellular communication between mouse hepatocytes by tumor promoters. Toxicol Appl Pharmacol. 87: 111-20.
58. Ishida E, Yamada M, Horiguchi K, Taguchi R, Ozawa A, et al. (2011) Attenuated expression of menin and p27 (Kip1) in an aggressive case of multiple endocrine neoplasia type 1 (MEN1) associated with an atypical prolactinoma and a malignant pancreatic endocrine tumor. Endocrine J. 58: 287-296.
59. He W, Wang X, Chen L, Guan X, (2012) A crosstalk imbalance between p27 (kip1) and its interacting molecules enhances breast carcinogenesis. Cancer Biother Radiopharm 27: 399-402.
60. Sun SH, Hung HC, Huang C, Lin JK, (2012) Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin. Eur J Pharmacol 690: 22-30.
61. Lu M, Zhao Y, Xu F, Wang Y, Xiang J, et al. (2012) The expression and prognosis of FOX3a and Skp2 in human ovarian cancer. Med Oncol 29: 3409-3415.
62. Huang HC, Lin CL, Lin JK, (2011) 1,2,3,4,6-penta-O-galloyl-β-D-glucose, quercetin, curcumin and lycopene induce cell-cycle arrest in MDA-MB-231 and BT474 cells through downregulation of Skp2 protein. J Agric Food Chem. 59: 6765-6775.
63. Giacomini D, Páez-Pereda M, Theodoropoulou M, Labeur M, Refojo D, et al. (2006) Bone morphogenetic protein-4 inhibits corticotroph tumor cells: involvement in the retinoic acid inhibitory action. Endocrinology 147: 247-256.
64. Liu NA, Jiang H, Ben-Shlomo A, Wawrowsky K, Fan XM, et al. (2011) Targeting zebrafish and murine pituitary corticotroph tumors with a cyclin-dependent kinase (CDK) inhibitor. Proc Natl Acad Sci 108: 8414-8419.
65. Florio T, (2008) Molecular mechanisms of the antiproliferative activity of somatostatin receptors (SSTRs) in neuroendocrine tumors. Front Biosci (13): 822-840.
66. Hofland LJ, Lamberts SW, Feelders RA, (2010) Role of somatostatin receptors in normal and tumoral pituitary corticotropic cells. Neuroendocrinology. 2010 92Suppl 1: 11-6.
67. Tani Y, Sugiyama T, Izumiyama H, Yoshimoto T, Yamada S, et al. (2011) Differential gene expression profiles of POMC-related enzymes, transcription factors and receptors between non-pituitary and pituitary ACTH-secreting tumors.Endocr J. 58: 297-303.